By Marcus Devlin
Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.
Elliott Management Takes Stake in CCC Intelligent Solutions as Insurtech Firm Explores Sale
Activist investor Elliott Management has taken a stake in CCC Intelligent Solutions, an insurance software firm that has hired Morgan Stanle
AI Optimism Drives S&P 500 to 1.2% Weekly Gain as SK Hynix Debuts on Nasdaq
The S&P 500 gained 1.2% this week as AI optimism lifted tech stocks. SK Hynix's Nasdaq debut surged 13%, while Hewlett Packard Enterprise an
Apple Sues OpenAI Over Alleged Theft of Hardware Trade Secrets by Ex-Employees
Apple has filed a lawsuit against OpenAI, alleging two ex-employees stole hardware trade secrets to accelerate OpenAI's consumer device effo
BHP Eyes $1.5–$2 Billion Chile Asset Sale to Sharpen Copper Focus
BHP is reportedly weighing the sale of a desalination plant and electricity transmission assets in Chile, potentially raising $1.5–$2 billio
SK Hynix CEO Warns AI Memory Shortage Could Peak in 2027
SK Hynix CEO Kwak Noh-jung says AI demand for high-bandwidth memory is growing faster than supply, with the shortage peaking in 2027. The ch
Buyout Giants Circle Segafredo Zanetti as QuattroR Weighs Sale of Majority Stake
QuattroR is exploring a sale of its majority stake in Segafredo Zanetti, the Italian coffee giant behind brands like Segafredo and Chock ful
Apollo Goes Two Ways: $7.65B EasyJet Bid and €3B Bayer Contraceptives Deal
Apollo Global Management is pursuing two very different deals: a $7.65 billion bid for airline EasyJet and a €3 billion investment in Bayer'
Warburg Pincus and ADIA Near $7 Billion Deal for Rare-Disease Pharmacy PANTHERx
Private equity firm Warburg Pincus, alongside Abu Dhabi Investment Authority, is nearing a deal to buy PANTHERx Rare for more than $7 billio
SK Hynix's $26.5B US Debut Opens 14% Higher, Putting AI Chips Back in Focus
SK Hynix's US stock debut opened 14% above its offering price, drawing $26.5 billion in demand. The move gives US investors easier access to
Pfizer's Q2 Profit May Miss Estimates as COVID Drug Sales Decline
RBC Capital Markets expects Pfizer's second-quarter earnings per share to come in at $0.66, slightly below the $0.68 consensus, as sales of
AtkinsRealis Partners with Indigenous-Owned Scout to Boost Infrastructure Bids
AtkinsRealis has signed a nonbinding agreement with Indigenous-owned Scout Engineering & Consulting to collaborate on infrastructure and com
Eurozone Inflation Cools in France and Germany as Deal Activity Heats Up
France and Germany's June inflation eased, signaling potential ECB rate cuts. Meanwhile, Apollo topped Castlelake's bid for EasyJet and Voda